Myocardial changes in newborn piglets fed sow milk or milk replacer diets containing different levels of erucic acid.
This study was undertaken to determine whether the neonate was more susceptible to the effects of dietary erucic acid (22:1n-9) than the adult. Newborn piglets were used to assess the safety of different levels of 22:1n-9 on lipid and histological changes in the heart. Newborn piglets showed no myocardial lipidosis as assessed by oil red 0 staining, but lipidosis appeared with consumption of sow milk and disappeared by seven days of age. Milk replacer diets containing soybean oil, or rapeseed oil mixtures with up to 5% 22:1n-9 in the oil, or 1.25% in the diet, gave trace myocardial lipidosis. Rapeseed oil mixtures with 7 to 42.9% 22:1n-9 showed definite myocardial lipidosis in newborn piglets, which correlated to dietary 22:1n-9, showing a maximum after one week on diet. The severity of the lipidosis was greater than observed previously with weaned pigs. There were no significant differences among diets in cardiac lipid classes except for triacylglycerol (TAG), which increased in piglets fed a rapeseed oil with 42.9% 22:1n-9. TAG showed the highest incorporation of 22:1n-9, the concentration of 22:1n-9 in TAG was similar to that present in the dietary oil. Among the cardiac phospholipids, sphingomyelin and phosphatidylserine had the highest, and diphosphatidylglycerol (DPG) the lowest level of 22:1n-9. The low content of 22:1n-9 in DPG of newborn piglets is not observed in weaned pigs and rats fed high erucic acid rapeseed oil. The relative concentration of saturated fatty acids was lowered in all cardiac phospholipids of piglets fed rapeseed oils, possibly due to the low content of saturated fatty acids in rapeseed oils. The results suggest that piglets fed up to 750 mg 22:1n-9/kg body weight/day showed no adverse nutritional or cardiac effects.
Kramer
J K
JK
Animal Research Center, Agriculture Canada, Ottawa, Ontario.
Farnworth
E R
ER
Johnston
K M
KM
Wolynetz
M S
MS
Modler
H W
HW
Sauer
F D
FD
D000818:Animals; D000831:Animals, Newborn / Q000502:physiology*; D004042:Dietary Fats, Unsaturated / Q000494:pharmacology*; D004883:Erucic Acids / Q000494:pharmacology*; D005227:Fatty Acids / Q000378:metabolism; D005260:Female; D005526:Food, Formulated; D006321:Heart / Q000187:drug effects* / Q000254:growth & development; D006801:Humans; D007223:Infant; D007225:Infant Food; D050356:Lipid Metabolism; D008064:Lipidoses / Q000139:chemically induced; D008297:Male; D008892:Milk / Q000737:chemistry*; D009206:Myocardium / Q000378:metabolism / Q000473:pathology; D009336:Necrosis; D009929:Organ Size / Q000187:drug effects; D013552:Swine; D014280:Triglycerides / Q000737:chemistry / Q000378:metabolism
D004042:Dietary Fats, Unsaturated; D004883:Erucic Acids; D005227:Fatty Acids; D014280:Triglycerides; C049811:erucic acid